Summary:
- This preprint article describes the development of a novel gene editing technology called CRISPR-Cas13d, which can be used for targeted RNA editing in human cells.
- The researchers demonstrate that CRISPR-Cas13d can efficiently and precisely edit RNA sequences, with potential applications in treating genetic diseases and viral infections.
- The study provides evidence that CRISPR-Cas13d is a promising tool for advancing RNA-based therapeutics and expanding the capabilities of gene editing technologies.